...
机译:Andexanet与凝血酶原浓缩物的成本比较在出血后直接因子XA抑制剂逆转
NYU Sch Med Dept Neurol New York NY 10016 USA;
NYU Langone Hlth Dept Pharm New York NY USA;
NYU Sch Med Dept Neurol New York NY 10016 USA;
NYU Sch Med Dept Neurol New York NY 10016 USA;
NYU Langone Hlth Dept Pharm New York NY USA;
NYU Langone Hlth Dept Pharm New York NY USA;
NYU Langone Hlth Dept Pharm New York NY USA;
DOAC; NOAC; Anticoagulation; Reversal; Coagulopathy; Hemostasis; Thrombosis; Cost; Intracranial hemorrhage; Direct factor Xa inhibitor;
机译:Andexanet与凝血酶原浓缩物的成本比较在出血后直接因子XA抑制剂逆转
机译:逆转华法林相关主要出血:活化凝血酶原浓缩浓缩物与4系子凝血酶体复合物浓缩物
机译:Andexanet Alfa和凝血酶原浓缩物的荟萃分析,浓缩浓缩因子XA抑制剂相关的重大出血
机译:Andexanet alfa在非临床和临床研究中逆转Xa因子抑制剂诱导的抗凝作用
机译:逆转华法林相关凝血病:凝血酶原浓缩物与颅内出血患者的老年患者新鲜冷冻血浆
机译:Andexanet与凝血酶原复合物浓缩物:在体外凝血酶产生中因子XA抑制剂逆转的差异
机译:Andexanet Alfa与4系子凝血酶原浓缩物,用于颅内出血中因子XA抑制剂的逆转